175
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Identification of colorectal neoplasia by using serum bile acid profile

, , , , , , , , , , , , , , , , , & show all
Pages 462-467 | Received 24 Nov 2020, Accepted 05 Apr 2021, Published online: 30 Apr 2021

References

  • American Cancer Society. 2020. About colorectal cancer. https://www.cancer.org
  • Bajor, A., Gillberg, P.G., and Abrahamsson, H., 2010. Bile acids: short and long term effects in the intestine. Scandinavian journal of gastroenterology, 45 (6), 645–664.
  • Bayerdorffer, E., et al., 1993. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology, 104 (1), 145–151.
  • Bayerdorffer, E., et al., 1994. Variation of serum bile acids in patients with colorectal adenomas during a one-year follow-up. Digestion, 55 (2), 121–129.
  • Bayerdorffer, E., et al., 1995. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut, 36 (2), 268–273.
  • Bianchini, F., et al., 1989. Effect of dietary fat, starch and cellulose on fecal bile acids in mice. The journal of nutrition, 119 (11), 1617–1624.
  • Brenner, H., Stock, C., and Hoffmeister, M., 2015. Colorectal cancer screening: the time to act is now. BMC medicine, 13 (1), 262.
  • Brock, W.J., et al., 2018. Bile acids as potential biomarkers to assess liver impairment in polycystic kidney disease. International journal of toxicology, 37 (2), 144–154.
  • Cheng, K. and Raufman, J. P., 2005. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochemical pharmacology, 70 (7), 1035–1047.
  • Coomans, D.H. and de Vel, O., 1995. Pattern analysis and classification. Chemometrics in environmental chemistry – statistical methods. Berlin, Germany: Springer-Verlag Berlin Heidelberg, 279–324.
  • Costarelli, V., et al., 2002. A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey. British journal of cancer, 86 (11), 1741–1744.
  • Dawson, P.A., et al., 2005. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. Journal of biological chemistry, 280 (8), 6960–6968.
  • de Boer, A.G., et al., 2015. Interventions to enhance return-to-work for cancer patients. Cochrane database of systematic reviews, 2, CD007569.
  • Debruyne, P.R., et al., 2001. The role of bile acids in carcinogenesis. Mutation research, 480–481, 359–369.
  • Debruyne, P.R., et al., 2002. Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene, 21 (44), 6740–6750.
  • DeRubertis, F.R., Craven, P.A., and Saito, R., 1984. Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products. Journal of clinical investigation, 74 (5), 1614–1624.
  • Giovannucci, E., Colditz, G.A., and Stampfer, M.J., 1993. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology, 105 (1), 130–141.
  • He, X., et al., 2017. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes. Oncotarget, 8 (17), 29116–29124.
  • Heiss, J.A. and Brenner, H., 2017. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting. Clinical epigenetics, 9 (1), 24.
  • Hori, T., et al., 1998. Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats. Cancer letters, 124 (1), 79–84.
  • Huang, J., et al., 2017a. A prospective study of serum metabolites and glioma risk. Oncotarget, 8 (41), 70366–70377.
  • Huang, J., et al., 2017b. Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor. Oncotarget, 8 (28), 45190–45199.
  • Jee, S.H., et al., 2018. Metabolomics profiles of hepatocellular carcinoma in a Korean prospective cohort: the Korean cancer prevention study-II. Cancer prevention research, 11 (5), 303–312.
  • Kuhn, T., et al., 2019. Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective study. Journal of the national cancer institute, 112: 516–524.
  • Kurtz, W.J. and Leuschner, U., 1983. Bile acids in patients suffering from colorectal carcinoma–a pilot study. Tokai journal of experimental and clinical medicine, 8, 59–69.
  • Lagergren, J., Ye, W., and Ekbom, A., 2001. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis. Gastroenterology, 121 (3), 542–547.
  • Murakami, M., et al., 2018. Detection of gut dysbiosis due to reduced clostridium subcluster XIVa using the fecal or serum bile acid profile. Inflammatory bowel diseases, 24 (5), 1035–1044.
  • Nagengast, F.M., Grubben, M.J., and van Munster, I.P., 1995. Role of bile acids in colorectal carcinogenesis. European journal of cancer, 31 (7–8), 1067–1070.
  • Ochsenkuhn, T., et al., 1999. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer, 85 (8), 1664–1669.
  • Pearson, J.R., Gill, C.I., and Rowland, I.R., 2009. Diet, fecal water, and colon cancer–development of a biomarker. Nutrition reviews, 67 (9), 509–526.
  • Proungvitaya, S., et al., 2017. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. Oncology letters, 14 (4), 4943–4948.
  • Reddy, B.S., et al., 1977. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer research, 37, 3238–3242.
  • Reddy, B.S. and Wynder, E.L., 1973. Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. JNCI: journal of the national cancer institute, 50 (6), 1437–1442.
  • Reddy, B.S. and Wynder, E.L., 1977. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer, 39 (6), 2533–2539.
  • Ridlon, J.M. and Bajaj, J.S., 2015. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta pharmaceutica sinica B, 5 (2), 99–105.
  • Ridlon, J.M., Kang, D.J., and Hylemon, P.B., 2006. Bile salt biotransformations by human intestinal bacteria. Journal of lipid research, 47 (2), 241–259.
  • Russell, D.W., 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annual review of biochemistry, 72 (1), 137–174.
  • Schreuders, E.H., et al., 2015. Colorectal cancer screening: a global overview of existing programmes. Gut, 64 (10), 1637–1649.
  • Sutherland, L.A. and Bird, R.P., 1994. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer letters, 76 (2–3), 101–107.
  • Vahabi, F., et al., 2017. Staging of colorectal cancer using serum metabolomics with (1)HNMR Spectroscopy. Iranian journal of basic medical sciences, 20, 835–840.
  • van Faassen, A., et al., 1997. Plasma deoxycholic acid is related to deoxycholic acid in faecal water. Cancer letters, 114 (1–2), 293–294.
  • Vatandoost, N., et al., 2016. Early detection of colorectal cancer: from conventional methods to novel biomarkers. Journal of cancer research and clinical oncology, 142 (2), 341–351.
  • Wong, M.H., Oelkers, P., and Dawson, P.A., 1995. Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. Journal of biological chemistry, 270 (45), 27228–27234.
  • Young, G.P., et al., 2016. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer. Cancer medicine, 5 (10), 2763–2772.
  • Zimber, A., et al., 1994. Inhibition of proliferation and induction of monocytic differentiation on HL60 human promyelocytic leukemia cells treated with bile acids in vitro. International journal of cancer, 59 (1), 71–77.
  • Zimber, A., et al., 2000. Functional interactions between bile acids, all-trans retinoic acid, and 1,25-dihydroxy-vitamin D3 on monocytic differentiation and myeloblastin gene down-regulation in HL60 and THP-1 human leukemia cells. Cancer research, 60, 672–678.
  • Zimber, A. and Gespach, C., 2008. Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential. Anti-Cancer agents in medicinal chemistry, 8 (5), 540–563.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.